Pneumococcal VaccineAVI version 0.1课件.ppt

精品文档 Wth such an alliance the mapping of roles and responsibilities is essential, so setting up an integrated and easy to follow work plan is essential Country willingness to introduce and co pay, donors willing to fund, vaccine performance which justifies recommendation by WHO and IAC, industry with sufficient capacity and affordable (declining) price especially over time, to enable sustainable introduction to GAVI eligible countries Compare penta demand forecast overlayed on the rota and pneumo (current) forecasts Both are faster, justified by good understanding of application process and earlier SAGE recommendation However bear in mind we are launching 2 vaccines not 1. Also the concern over affordability Pneumococcal VaccineAVI version 0.1 Stefano Malvolti Director Strategic Vaccine Supply AVI Project August 25th, 2009 Objectives of today Provide overview on AVI strategic forecasting process and responsibility for Pneumococcal vaccine Provide overview on AVI version 0.1 Pneumococcal vaccine strategic forecast assumptions Discuss AVI version 0.1 strategic forecast results and variability Address questions from the audience 精品文档 Country willingness to introduce Informed country decision Sufficient and appropriate vaccine Donors willing to fund Sustainable introduction Accelerated Vaccine Introduction (AVI) GAVI’s “product launch” project for Pneumo and Rota Strategic Vaccine Supply “Support and trigger evidence-based decisions that increase effectiveness and efficiency of introduction activities of the AVI project by providing high-quality, consistent, timely and transparent strategic demand forecasts for Pneumococcal and Rotavirus vaccines, ensuring seamless interface with UNICEF procurement plans and providing single point of contact for all strategic forecasting information” Accelerated Vaccine Introduction 精品文档 SVS sub-team ensure input from all partner organisations Core Team: Ann Ottosen UNICEF SD Deborah Atherley AVI-TAC (Rota ADIP) Gill Meyers WHO L